EMA: Reinforced EU/US collaboration on medicines

The EC/EMA and FDA will continue their strong cooperation in numerous activities under their responsibilities, including innovation. The activities planned in the next couple of years will need to take into account EMA’s business continuity needs during and after its relocation to Amsterdam. This document was originally posted by the EMA here. 

Read More

"The Time is Now to Professionalize the Clinical Trial Industry"

    “It’s a sin not to [advance] professionalization in the clinical trial industry,” Robert O’Neill, the U.S. Food and Drug Administration’s (FDA’s) senior statistical advisor for the Office of Translational Sciences in the Center for Drug Evaluation and Research, told attendees of the DIA 2018 Global Annual Meeting in Boston this week. “It’s really…

Read More

I AM IFAPP: KYOKO IMAMURA

  What was your motivation to join IFAPP? I learned of IFAPP when I joined Japanese member association more than two decades ago, but little information was available in those days. I rarely received news from House of Delegate meeting / General Assembly and ICPM. Since we started our regular educational seminars in Japan in…

Read More

FDA Basics for Industry

  How do i know if my product is regulated by the FDA? It depends on what the product is and how it is marketed. For more information, see FDA’s general navigation guide for manufacturers of FDA-regulated products and start-ups. what should I expect during an inspection? FDA may conduct an inspection of your operation…

Read More

Ten years promoting high-quality scientific research in paediatric medicines

The second day of the workshop is reserved for discussions among the members of Enpr-EMA and its coordinating group. The coordinating group will define priority tasks for 2018–19 based on the feedback received from stakeholders. Individuals interested in attending the first day of the workshop are invited to send a completed registration form to enprema@ema.europa.eu before 28 May 2018.…

Read More

Updated rules for clinical development of vaccines

26/04/2018 EMA launches public consultation on revised guideline on clinical evaluation of vaccines The European Medicines Agency (EMA) has released a revised guideline on the clinical evaluation of vaccines for a six-month public consultation. Stakeholders are invited to send their comments by 30 October 2018 to vwp@ema.europa.eu using the template provided in the guideline. Vaccination is one of the greatest breakthroughs in modern medicine.…

Read More

Civil society representatives wanted…

Civil society representatives wanted for EMA’s Management Board and Pharmacovigilance Committee 30/04/2018 Submission deadline is 8 June 2018 The European Commission has launched a call for expressions of interest for civil society representatives to join the Management Board of the European Medicines Agency (EMA), as well as the Agency’s Pharmacovigilance Risk Assessment Committee(PRAC). This is an opportunity for civil society representatives to…

Read More

EMA 2017 annual report published

02/05/2018 Report highlights major achievements and includes key figures The 2017 annual report published today provides an overview of the work of the European Medicines Agency (EMA) and highlights last year’s major achievements in protecting and promoting public and animal health in the European Union (EU). EMA’s annual report draws attention to some of the Agency’s main…

Read More

The PharmaTrain Syllabus for Pharmaceutical Medicine / Medicines Development Science (Version 2.0) 2018

To all IFAPP National Member Associations (NMAs) and Individual Affiliates  We are pleased to introduce the 2018 PharmaTrain Syllabus (2018 Syllabus).*  IFAPP, The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine, together with The PharmaTrain Federation (PTF) and The Faculty of Pharmaceutical Medicine of the UK Royal Colleges of Physicians (FPM)  jointly sponsored…

Read More

I AM IFAPP: JOHANNA SCHENK

Today we are starting a new section on the IFAPP website, recognizing the value and professionalism of relevant members of IFAPP who have greatly contributed to the growth and development of our Federation: “I am IFAPP”. The first person to talk to all of us and comment on her experience is Dr. Johanna Schenk, Past…

Read More